Covalis Capital’s Oscar Health OSCR Stock Holding History

Covalis Capital’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-68,161	Closed	-$1.83M	–	139
2021 Q1	$1.83M	Buy	+68,161	New	+$2.13M	0.38%	43

Other funds holding OSCR

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

FFIM

Founders Fund IV Management San Francisco, California $1.21M AUM

Formation8 Los Altos, California $67.6M AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Covalis Capital's OSCR Position: Q2 2021 in Review

Covalis Capital sold out of Oscar Health (OSCR) in Q2 2021, closing a stake of 68,161 shares — an estimated $1.83M sold.

Covalis Capital first reported a position in OSCR in Q1 2021 and held it in 1 quarter. The position peaked at $1.83M in Q1 2021. 77 funds tracked by Wall St. Rank hold OSCR as of Q2 2021.

Covalis Capital reported no remaining Oscar Health position as of Q2 2021 after selling out during the quarter.
Covalis Capital sold 68,161 Oscar Health shares in Q2 2021, an estimated $1.83M.
Covalis Capital first reported a position in Oscar Health in Q1 2021 and held it in 1 quarter.
Covalis Capital's Oscar Health position peaked at $1.83M in Q1 2021.
77 funds tracked by Wall St. Rank held Oscar Health as of Q2 2021.

Based on Covalis Capital's 13F filing for Q2 2021, filed 16 Aug 2021.